Claus Rödel
Department of Radiation Oncology
University of Erlangen-Nürnberg
Erlangen
Germany
Name/email consistency: high
- Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. Rödel, C., Liersch, T., Hermann, R.M., Arnold, D., Reese, T., Hipp, M., Fürst, A., Schwella, N., Bieker, M., Hellmich, G., Ewald, H., Haier, J., Lordick, F., Flentje, M., Sülberg, H., Hohenberger, W., Sauer, R. J. Clin. Oncol. (2007)
- Trimodality treatment and selective organ preservation for bladder cancer. Rödel, C., Weiss, C., Sauer, R. J. Clin. Oncol. (2006)
- Organ preservation by combined modality treatment in bladder cancer: the European perspective. Rödel, C., Weiss, C., Sauer, R. Semin. Radiat. Oncol (2005)
- Neoadjuvant radiotherapy and radiochemotherapy for rectal cancer. Rödel, C., Sauer, R. Recent Results Cancer Res. (2005)
- Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. Rödel, C., Martus, P., Papadoupolos, T., Füzesi, L., Klimpfinger, M., Fietkau, R., Liersch, T., Hohenberger, W., Raab, R., Sauer, R., Wittekind, C. J. Clin. Oncol. (2005)
- What is the role of radiotherapy in bladder-preserving cancer therapy?. Rödel, C., Sauer, R. Nature Clinical Practice. Oncology (2005)
- Neoadjuvant radiochemotherapy in rectal cancer: for which patients and tumor stages?. Rödel, C., Sauer, R. Front. Radiat. Ther. Oncol (2004)
- Current status of radiation therapy and combined-modality treatment for bladder cancer. Rödel, C. Strahlenther. Onkol (2004)
- Radiotherapy and concurrent radiochemotherapy for rectal cancer. Rödel, C., Sauer, R. Surg. Oncol (2004)
- Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor. Rödel, C., Haas, J., Groth, A., Grabenbauer, G.G., Sauer, R., Rödel, F. Int. J. Radiat. Oncol. Biol. Phys. (2003)
- Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. Rödel, C., Grabenbauer, G.G., Papadopoulos, T., Hohenberger, W., Schmoll, H.J., Sauer, R. J. Clin. Oncol. (2003)
- Invasive bladder cancer: organ preservation by radiochemotherapy. Rödel, C., Grabenbauer, G.G., Kühn, R., Dunst, J., Papadopoulos, T., Schrott, K.M., Sauer, R. Front. Radiat. Ther. Oncol (2002)
- Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Rödel, C., Grabenbauer, G.G., Papadopoulos, T., Bigalke, M., Günther, K., Schick, C., Peters, A., Sauer, R., Rödel, F. Int. J. Radiat. Oncol. Biol. Phys. (2002)
- Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. Rödel, C., Grabenbauer, G.G., Kühn, R., Zörcher, T., Papadopoulos, T., Dunst, J., Schrott, K.M., Sauer, R. Int. J. Radiat. Oncol. Biol. Phys. (2002)
- Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. Rödel, C., Grabenbauer, G.G., Kühn, R., Papadopoulos, T., Dunst, J., Meyer, M., Schrott, K.M., Sauer, R. J. Clin. Oncol. (2002)
- Radiotherapy is an effective treatment for high-risk T1-bladder cancer. Rödel, C., Dunst, J., Grabenbauer, G.G., Kühn, R., Papadopoulos, T., Schrott, K.M., Sauer, R. Strahlenther. Onkol (2001)
- Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation. Rödel, C., Grabenbauer, G.G., Rödel, F., Birkenhake, S., Kühn, R., Martus, P., Zörcher, T., Fürsich, D., Papadopoulos, T., Dunst, J., Schrott, K.M., Sauer, R. Int. J. Radiat. Oncol. Biol. Phys. (2000)
- Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer. Rödel, C., Grabenbauer, G.G., Schick, C., Papadopoulos, T., Hohenberger, W., Sauer, R. Strahlenther. Onkol (2000)